financetom
Business
financetom
/
Business
/
Magna Up 6.4% In US Premarket
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Magna Up 6.4% In US Premarket
Nov 4, 2024 11:54 AM

05:57 AM EDT, 11/01/2024 (MT Newswires) -- Magna (MG.TO, MGA) was at last look up 6.4% in US premarket on Friday despite reporting Q3 adjusted earnings Friday of US$1.28 per diluted share, down from $1.46 a year earlier. Analysts polled by Capital IQ expected $1.40.

Sales for the quarter ended Sept. 30 were $10.28 billion, compared with $10.69 billion a year earlier. Analysts polled by Capital IQ expected $10.39 billion.

The company said its board approved a one-year normal course issuer bid to purchase up to about 28.5 million of its common shares, or about 10% of its public float, expected to start Nov. 7, subject to the Toronto Stock Exchange's approval.

"We continue to mitigate industry headwinds including lower production volumes in each of our core regions. Our ongoing initiatives and results to date reinforce our conviction in our free cashflow outlook this year and beyond. As we continuously seek to optimize value creation, we are resuming share repurchases in the fourth quarter -- ahead of our prior plan," said Swamy Kotagiri, Magna's Chief Executive Officer.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
IonQ Closes Vector Atomic Acquisition
IonQ Closes Vector Atomic Acquisition
Oct 7, 2025
08:13 AM EDT, 10/07/2025 (MT Newswires) -- IonQ ( IONQ ) said Tuesday it closed its acquisition of California-based quantum sensing company Vector Atomic. The company said the all-stock deal adds precision atomic clocks, inertial sensors, and synchronization hardware to its computing and networking stack. IonQ ( IONQ ) shares were up over 2% in recent premarket activity. ...
Telomir Says Investigational Therapy Reactivates Tumor Suppressor Genes in Preclinical Models
Telomir Says Investigational Therapy Reactivates Tumor Suppressor Genes in Preclinical Models
Oct 7, 2025
08:17 AM EDT, 10/07/2025 (MT Newswires) -- Telomir Pharmaceuticals ( TELO ) said Tuesday that preclinical results show that its investigational therapy Telomir-1 reactivated two tumor suppressor genes, potentially preventing the spread of cancer and improving responses to chemotherapy. The results showed that the experimental therapy reactivated the MASPIN and RASSF1A genes through DNA methylation reset in prostate cancer models,...
Fractyl Health Says Obesity Drug Candidate Shows Weight Loss in Preclinical Trial
Fractyl Health Says Obesity Drug Candidate Shows Weight Loss in Preclinical Trial
Oct 7, 2025
08:17 AM EDT, 10/07/2025 (MT Newswires) -- Fractyl Health ( GUTS ) said Tuesday that new preclinical data from its obesity candidate RJVA-002 showed 30% weight loss in mice after a single dose, with no adverse effects observed. The company said the study used a diet-induced obesity model with humanized GIP receptors and demonstrated a dose-dependent reduction in body weight...
Redwire Plans to Appoint Chris Edmunds as Chief Financial Officer
Redwire Plans to Appoint Chris Edmunds as Chief Financial Officer
Oct 7, 2025
08:17 AM EDT, 10/07/2025 (MT Newswires) -- Redwire ( RDW ) said Tuesday it intends to appoint Chris Edmunds as chief financial officer, replacing Jonathan Baliff, who will retire, effective Nov. 30. Edmunds currently serves as the company's chief accounting officer. Baliff will serve as a consultant through December 2026, Redwire ( RDW ) said. The company's shares were up...
Copyright 2023-2026 - www.financetom.com All Rights Reserved